We further performed immunohistochemistry against human specific cytoplasmic antigen (STEM-121) and GBM specific markers (GFAP, Nestin, and SOX2) to confirm that the lung nodules were composed with human GBM cells. The gene discussed is GFAP; the disease is glioblastoma.